Le Lézard
Classified in: Science and technology
Subjects: CALENDAR OF EVENTS, Conference Calls/ Webcasts

AMD to Report Fiscal Third Quarter 2023 Financial Results


SANTA CLARA, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) announced today that it will report fiscal third quarter 2023 financial results on Tuesday, Oct. 31, 2023, after the close of market. Management will conduct a conference call to discuss these results at 5:00 p.m. EDT / 2:00 p.m. PDT. Interested parties are invited to listen to the webcast of the conference call via AMD's Investor Relations website ir.amd.com.

About AMD
For more than 50 years AMD has driven innovation in high-performance computing, graphics and visualization technologies. Billions of people, leading Fortune 500 businesses and cutting-edge scientific research institutions around the world rely on AMD technology daily to improve how they live, work and play. AMD employees are focused on building leadership high-performance and adaptive products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) website, blog, LinkedIn, Facebook and Twitter pages.

AMD, the AMD Arrow logo and the combination thereof are trademarks of Advanced Micro Devices, Inc. Other names are for informational purposes only and may be trademarks of their respective owners.

Contact
Drew Prairie
AMD Communications
512-602-4425
[email protected]

Mitch Haws
AMD Investor Relations
408-749-3124
[email protected]



These press releases may also interest you

at 12:06
ExxonMobil Hit with $725M Verdict for Failure to Warn About Cancer-Causing Benzene in Gasoline
A Philadelphia jury has returned a $725.5 million verdict against ExxonMobil, finding the company's failure to warn about known health risks of exposure to cancer-causing benzene in its petroleum products was responsible for a former service station...

at 12:05
Be Biopharma Announces New Preclinical Data for Novel B Cell Medicine for the Potential Treatment of Hypophosphatasia
Be Biopharma, Inc. ("Be Bio"), a company pioneering the discovery and development of Engineered B Cell Medicines (BCMs), today presented results from new preclinical research demonstrating production of active ALP by a BCM, which highlights BCMs as a...

at 12:05
Kondukto announces Bring-Your-Own-Data (BYOD)
Today Kondukto Inc., the leading Application Security Orchestration & Posture Management platform for cloud and on-premise workloads, announces "Bring-Your-Own-Data" (BYOD) which allows enterprises to integrate their unique data-streams into the...

at 11:50
EGLE Therapeutics Strengthens its Leadership Team with the Appointment of Pejvack Motlagh, MD, MSc, as Chief Medical Officer and its Board of Directors with Appointment of John Celebi, MBA, as Independent Board Member
EGLE Therapeutics, a clinical-stage biotechnology company uniquely positioned to advance the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Pejvack Motlagh MD, MSc, as Chief...

at 11:35
Productivity in the AI Era: ChatGPT's Role in Transforming Business Operations Outlined in New Blueprint From Info-Tech Research Group
Generative AI tools like ChatGPT promise to reshape traditional workflows by streamlining tasks, automating research, and freeing up...

at 11:32
IDTechEx Explores Printed Electronics in Electrified and Autonomous Mobility
Electrification, autonomy, and vehicle ownership saturation are causing a technological revolution in the automotive sector. These automotive meta-trends are driving drastic changes in electronic component requirements and present a high-volume...

More news about Science and technology...


News published on and distributed by: